EcoDrugPlus

Sphingosine-1-Phosphate Receptor 1

Ensembl ID : ENSKMAG00000006837
Gene Symbol: S1PR1
3 Cross references
200 Possible Orthologues:

Spleen Associated Tyrosine Kinase

Ensembl ID : ENSKMAG00000011893
Gene Symbol: SYK
3 Cross references
200 Possible Orthologues:

Steroid 17-Alpha-Hydroxylase/17,20 Lyase

Ensembl ID : ENSKMAG00000017730
Gene Symbol: LOC108239115
3 Cross references
210 Possible Orthologues:

Steroid 5 Alpha-Reductase 2

Ensembl ID : ENSKMAG00000007893
Gene Symbol: SRD5A2
3 Cross references
191 Possible Orthologues:

Sterol O-Acyltransferase 1

Ensembl ID : ENSKMAG00000022260
Gene Symbol: SOAT1
3 Cross references
210 Possible Orthologues:

Substance-P Receptor-Like

Ensembl ID : ENSKMAG00000016923
Gene Symbol: LOC108245379
3 Cross references
193 Possible Orthologues:

Tachykinin Receptor 1

Ensembl ID : ENSKMAG00000010517
Gene Symbol: TACR1
1 Cross references
194 Possible Orthologues:

Tachykinin Receptor 2

Ensembl ID : ENSKMAG00000020586
Gene Symbol: TACR2
3 Cross references
199 Possible Orthologues:

Tachykinin Receptor 3

Ensembl ID : ENSKMAG00000000112
Gene Symbol: TACR3
3 Cross references
208 Possible Orthologues:

Telomerase Reverse Transcriptase

Ensembl ID : ENSKMAG00000021731
Gene Symbol: TERT
3 Cross references
189 Possible Orthologues:

Thromboxane A2 Receptor

Ensembl ID : ENSKMAG00000007383
Gene Symbol: TBXA2R
3 Cross references
192 Possible Orthologues:

Thromboxane-A Synthase-Like

Ensembl ID : ENSKMAG00000021990
Gene Symbol: LOC108237514
3 Cross references
214 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).